Zimmer Biomet Holdings Business Segments
Business, geographic, and product segment breakdowns
Zimmer Biomet Holdings generates $8.4B in annual revenue across 4 key segments: Hips ($2.1B), Knees ($3.4B), SET ($2.2B), and Technology And Data Bone Cement And Surgical ($687.4M). The company-wide operating margin is 14.02%. Based on the Q1 2026 filing.
Latest FilingQ1 2026
Report Date2026-05-01
Market Cap$16.9B
P/E Ratio22.15
ROE6.07%